University Health Network, Toronto General Hospital
University Health Network, Toronto General Hospital
Toronto, Ontario, Canada6 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| In Vivo Lung Perfusion (IVLP) for Colorectal Cancer Metastatic to Lung | Digestive System Diseases, Digestive System Neoplasms, Neoplasm Metastasis, Neoplasms by Site, Neoplastic Processes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, colonic disorder, colorectal cancer, colorectal neoplasm, digestive system disorder, digestive system neoplasm, intestinal disorder, neoplasm, rectal disorder | Recruiting | Phase 1 | 2026-09-29 | NCT05611034 | |
| Trifecta-Lung cfDNA-MMDx Study | Lung Transplantation | Recruiting | Not stated | 2026-07-17 | NCT05837663 | |
| Diagnostic and Therapeutic Applications of Microarrays in Lung Transplantation | Lung Transplant Rejection | Recruiting | Not stated | 2026-05-28 | NCT02812290 | |
| Combination Letermovir and Standard of Care Antiviral for Enhanced Antiviral Response in Cytomegalovirus Infection in Lung Transplant Recipients | CMV; Lung Transplant Recipient | Recruiting | Phase 4 | 2026-02-17 | NCT07235683 | |
| Combined Light, ExVivo, and Antivirals for Recipients of Lungs From HBV Donors | Blood-Borne Infections, DNA Virus Infections, Digestive System Diseases, Hepadnaviridae infectious disease, Infections, hepatitis, hepatitis B virus infection, infectious disease, liver disorder, viral hepatitis, viral infectious disease | Recruiting | Phase 4 | 2025-11-17 | NCT07189377 | |
| Gemcitabine/Cisplatin/Nab-Paclitaxel and Rilvegostomig in Resectable iCCA | Biliary Tract Neoplasms, Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, biliary tract disorder, neoplasm | Not yet recruiting | Phase 2 | 2024-08-26 | NCT06569225 |